The treatment of uraemic osteopathy. II. The effect of 5,6-trans-25-hydroxycholecalciferol in terminal renal failure.
D000284:Administration, Oral; D000328:Adult; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D006887:Hydroxycholecalciferols